These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 16760833

  • 1. [Cutaneous vasculitis with necrotic ulcers in rheumatoid arthritis: treatment with anti-TNFalpha].
    Thirion L, Picard D, Mejjad O, Courville P, Le Loet X, Joly P.
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):453-5. PubMed ID: 16760833
    [Abstract] [Full Text] [Related]

  • 2. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
    Hellmann M, Jung N, Owczarczyk K, Hallek M, Rubbert A.
    Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
    [No Abstract] [Full Text] [Related]

  • 3. Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab).
    Benucci M, Li Gobbi F, Saviola G, Manfredi M.
    Rheumatol Int; 2008 Oct; 28(12):1253-5. PubMed ID: 18493770
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of ANCA-associated vascularitides].
    Guillevin L, Pagnoux C.
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [Abstract] [Full Text] [Related]

  • 5. Rituximab in patients with rheumatoid arthritis and vasculitis-associated cutaneous ulcers.
    Assmann G, Pfreundschuh M, Voswinkel J.
    Clin Exp Rheumatol; 2010 May; 28(1 Suppl 57):81-3. PubMed ID: 20412708
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.
    Guignard S, Gossec L, Bandinelli F, Dougados M.
    Clin Exp Rheumatol; 2008 May; 26(3 Suppl 49):S23-9. PubMed ID: 18799049
    [Abstract] [Full Text] [Related]

  • 7. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis.
    Tuveri M, Generini S, Matucci-Cerinic M, Aloe L.
    Lancet; 2000 Nov 18; 356(9243):1739-40. PubMed ID: 11095266
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab.
    Mitoma H, Horiuchi T, Tsukamoto H, Tamimoto Y, Kimoto Y, Uchino A, To K, Harashima S, Hatta N, Harada M.
    Arthritis Rheum; 2008 May 18; 58(5):1248-57. PubMed ID: 18438840
    [Abstract] [Full Text] [Related]

  • 9. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
    Wollina U, Hansel G, Koch A, Schönlebe J, Köstler E, Haroske G.
    Am J Clin Dermatol; 2008 May 18; 9(1):1-14. PubMed ID: 18092839
    [Abstract] [Full Text] [Related]

  • 10. [Antineutrophil cytoplasmic antibody associated vasculitis in a patient treated with adalimumab for a rheumatoid arthritis].
    Fournier A, Nony A, Rifard K.
    Nephrol Ther; 2009 Dec 18; 5(7):652-7. PubMed ID: 19482531
    [Abstract] [Full Text] [Related]

  • 11. Cutaneous vasculitis: diagnosis and management.
    Carlson JA, Cavaliere LF, Grant-Kels JM.
    Clin Dermatol; 2006 Dec 18; 24(5):414-29. PubMed ID: 16966021
    [Abstract] [Full Text] [Related]

  • 12. Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment.
    Ruppert M, De Clerck L, van Offel J, Hubens G, Balliu L, Vaneerdeweg W.
    Acta Chir Belg; 2006 Dec 18; 106(2):225-7. PubMed ID: 16761484
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis.
    Winkelstein A, Starz TW, Agarwal A.
    J Rheumatol; 1984 Apr 18; 11(2):162-6. PubMed ID: 6726715
    [Abstract] [Full Text] [Related]

  • 14. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.
    Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D'Agati VD.
    Nephrol Dial Transplant; 2005 Jul 18; 20(7):1400-6. PubMed ID: 15840673
    [Abstract] [Full Text] [Related]

  • 15. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis.
    Puéchal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E, Steinfeld S, Villoutreix C, Trèves R, Mariette X, Guillevin L, Club Rhumatismes et Inflammation (CRI).
    Ann Rheum Dis; 2008 Jun 18; 67(6):880-4. PubMed ID: 18037625
    [Abstract] [Full Text] [Related]

  • 16. Clinical approach to cutaneous vasculitis.
    Chen KR, Carlson JA.
    Am J Clin Dermatol; 2008 Jun 18; 9(2):71-92. PubMed ID: 18284262
    [Abstract] [Full Text] [Related]

  • 17. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS, Kay J, Doyle MK, Landewé R, Matteson EL, Wollenhaupt J, Gaylis N, Murphy FT, Neal JS, Zhou Y, Visvanathan S, Hsia EC, Rahman MU, GO-AFTER study investigators.
    Lancet; 2009 Jul 18; 374(9685):210-21. PubMed ID: 19560810
    [Abstract] [Full Text] [Related]

  • 18. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.
    Radstake TR, Svenson M, Eijsbouts AM, van den Hoogen FH, Enevold C, van Riel PL, Bendtzen K.
    Ann Rheum Dis; 2009 Nov 18; 68(11):1739-45. PubMed ID: 19019895
    [Abstract] [Full Text] [Related]

  • 19. Response of deep cutaneous vasculitis to infliximab.
    Uthman IW, Touma Z, Sayyad J, Salman S.
    J Am Acad Dermatol; 2005 Aug 18; 53(2):353-4. PubMed ID: 16021139
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients.
    Bartolucci P, Ramanoelina J, Cohen P, Mahr A, Godmer P, Le Hello C, Guillevin L.
    Rheumatology (Oxford); 2002 Oct 18; 41(10):1126-32. PubMed ID: 12364631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.